Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference
Notified -
Globe Newswire23-10-2025, 23:30
Nikkiso Sponsors 2023 Central German Hydrogen Congress and Presents Its Hydrogen Growth Strategy 30-08-2023, 17:00